MYT1L anticorps (C-Term)
Aperçu rapide pour MYT1L anticorps (C-Term) (ABIN1450034)
Antigène
Voir toutes MYT1L AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogène
- Rabbit polyclonal MYT1L antibody was raised against an 18 amino acid peptide near the carboxy terminus of human MYT1L.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store the antibody (in aliquots) at -20 °C.
-
-
- MYT1L (Myelin Transcription Factor 1-Like (MYT1L))
-
Autre désignation
- MYT1L
-
Sujet
- The myelin transcription factor 1 family, to which the myelin transcription factor 1-like protein (MYT1L) belongs, is expressed primarily in the developing central nervous system and recruits histone deacetylase (HDAC) to regulate neural transcription. Both MYT1L and the related protein MYT1 interact with SIN3B, a protein that mediates transcriptional repression by binding to HDACs, suggesting that the MYT1 family favor the silencing of genes during neural development. Recent studies suggest that polymorphisms of MYT1L may be associated with schizophrenia.Synonyms: KIAA1106, MYT1L, Myelin transcription factor 1-like protein
-
Poids moléculaire
- 130 kDa
-
ID gène
- 23040
-
NCBI Accession
- NP_055840
Antigène
-